A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone
Clinical trial NCT02675426 · COMPLETED
Trial details
- NCT number
- NCT02675426
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2017-04-21
- Enrollment
- 661
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.